7ACC1 - CAS 50995-74-9
Not Intended for Therapeutic Use. For research use only.
Category:
Inhibitor
Product Name:
7ACC1
Catalog Number:
50995-74-9
Synonyms:
DEAC; Coumarin D 1421; D 1421
CAS Number:
50995-74-9
Description:
7ACC1 selectively interferes with lactate fluxes in the lactate-rich tumor microenvironment and inhibits lactate influx but not efflux in tumor cells expressing MCT1 and MCT4 transporters. It delayed the growth of cervix SiHa tumors, colorectal HCT116 tumors, and orthoptopic MCF-7 breast tumors and also inhibited SiHa tumor relapse after treatment with cisplatin. Besides, 7ACC did not prevent the cell entry of the substrate-mimetic drug 3-bromopyruvate (3BP) through MCT1, and contributed to the inhibition of tumor relapse after 3BP treatment.
Molecular Weight:
261.27
Molecular Formula:
C14H15NO4
COA:
Inquire
MSDS:
Inquire
Targets:
MCT
Chemical Structure
CAS 50995-74-9 7ACC1

Related MCT Products


CAS 1448671-31-5 AZD3965

AZD3965
(CAS: 1448671-31-5)

AZD3965 is a selective inhibitor of monocarboxylate transporter 1 (MCT1) with a binding affinity of 1.6 nM, is 6 fold selective over MCT2 and does not inhibit M...

CAS 50995-74-9 7ACC1

7ACC1
(CAS: 50995-74-9)

7ACC1 selectively interferes with lactate fluxes in the lactate-rich tumor microenvironment and inhibits lactate influx but not efflux in tumor cells expressing...

CAS 496791-37-8 AR-C155858

AR-C155858
(CAS: 496791-37-8)

AR-C155858 is a novel inhibitor of the monocarboxylate transporters (MCTs) MCT1 and MCT2, but exhibits no activity at MCT4. It can be used to probe MCTs’ roles ...

CAS 56396-35-1 UK-5099

UK-5099
(CAS: 56396-35-1)

UK-5099 is a potent inhibitor of plasma membrane monocarboxylate transporters (MCTs) and the mitochondrial pyruvate carrier (MPC). It inhibits pyruvate-dependen...

AR-C117977
(CAS: 216685-07-3)

AR-C117977 is a potent MCT1 inhibitor that inhibited the rat MLR and was more potent than cyclosporin A (CsA). AR-C117977 can reduce vimmune responses both in v...

CAS 1472624-85-3 7ACC2

7ACC2
(CAS: 1472624-85-3)

7ACC2 did not influence the prothrombin time which, together with a good in vitro ADME profile, supports the potential of this new family of compounds to act as...